Search Results
62 items found for "P2Y12R inhibitors"
- Mutation Patterns Predict Drug Sensitivity in Acute Myeloid Leukemia
response prediction demonstrates high accuracy in predicting sensitivity to some drug classes, such as MEK inhibitors
- Student Flash Presentations | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Steichen Elucidating The Role Of GPR97/ADGRG3 In Neutrophil Biology Tyler Bernadyn Next Generation MBD2 inhibitors Brain angiogenesis inhibitor 3 (BAI3/ADGRB3), a member of the BAI1-3 subfamily of adhesion GPCRS, has from an alternative promoter in intron 17 Rashed Rezwan Parag Abstract "Brain-specific angiogenesis inhibitor Tyler Bernadyn on the web LinkedIn Next Generation MBD2 inhibitors for Brain Cancer Therapy Jesse Stillwell KCC-07 is an inhibitor that prevents MBD2 from binding to DNA, allowing re-expression of BAI1.
- A2aR on lung adenocarcinoma cells: A novel target for cancer therapy via recruiting and regulating tumor-associated macrophages
receptor (A2aR), a typical GPCR with a high affinity for adenosine, is widely expressed on immune cells, inhibiting We hypothesize that blocking A2aR on LUAD cells will inhibit the role of TAMs and control tumor growth Notably, the M2 polarization of TAMs can also be prevented by inhibiting A2aR in vitro.
- The combination of brentuximab vedotin and chidamide synergistically suppresses the proliferation of T-cell lymphoma cells through the enhancement of apoptosis
Results: Chidamide (tucidinostat), a novel histone deacetylase inhibitor, was found to have the greatest
- Clinical, pathophysiologic, genetic and therapeutic progress in Primary Bilateral Macronodular Adrenal Hyperplasia
tend to favor unilateral adrenalectomy, or less frequently, medical treatment with cortisol synthesis inhibitors
- Identification of S1PR4 as an immune modulator for favorable prognosis in HNSCC through machine learning
prognosis in HNSCC through machine learning Published date September 15, 2023 Abstract "The multikinase inhibitor
- Identification of Small-Molecule Antagonists Targeting the Growth Hormone Releasing Hormone Receptor (GHRHR)
In vitro results suggest that several of the novel small-molecule compounds could inhibit GHRH-induced specificity/selectivity of one of the most effective hit compounds indicated that the effect seen was via inhibition We therefore report the first nonpeptide antagonists of GHRHR and propose a structural basis for inhibition
- Pharmacological inhibition of neuropeptide Y receptors Y1 and Y5 reduces hypoxic breast cancer migration, proliferation, and signaling
< GPCR News < GPCRs in Oncology and Immunology Pharmacological inhibition of neuropeptide Y receptors This abundance is exploited for cancer imaging, but there is interest in pharmacological inhibition of receptor positive MCF7 cells were significantly less invasive in 3D spheres when NPY5R was specifically inhibited
- RGS20 promotes non-small cell lung carcinoma proliferation via autophagy activation and inhibition of the PKA-Hippo signaling pathway
Immunology RGS20 promotes non-small cell lung carcinoma proliferation via autophagy activation and inhibition Remarkably, inhibiting Hippo signaling with GA-017 promoted cell proliferation and activated autophagy Conclusion: Our findings indicate that RGS20 drives NSCLC cell proliferation by triggering autophagy via the inhibition
- The Effect of Cancer-Associated Mutations on Ligand Binding and Receptor Function - A Case for the 5-HT2C Receptor
The inhibitory potency of mesulergine was increased at E306A6.30 but not E306K6.30.
- Neurotoxicity and accumulation of CPPD quinone at environmentally relevant concentrations in Caenorhabditis elegans
Therefore, exposure to CPPDQ potentially resulted in neurotoxicity by inhibiting TGF-β, JNK MAPK, and The inhibition in JNK MAPK and ERK MAPKs signals in CPPDQ exposed nematodes was further related to alteration
- Full Agenda for Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Regions of a Holo-Adhesion GPCR Virginea de Araujo Farias Anti-Tumorigenic Role of Brain Angiogenesis Inhibitor characterization of a non-cleavable point mutant knock-in mouse, H381S Jesse Stillwell Next Generation MBD2 inhibitors
- CircFKBP5 Suppresses Apoptosis and Inflammation and Promotes Osteogenic Differentiation
hDPSCs and, functionally, reexpression of circFKBP5 attenuated LPS-induced apoptosis, inflammation, and inhibition CircFKBP5 could protect against LPS-induced apoptosis, inflammation, and osteogenic differentiation inhibition
- Posters | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
collecting duct specific GPR56 knockout mice Jianxiang Xue Anti-Tumorigenic Role of Brain Angiogenesis Inhibitor Jianxiang Xue on the web Zaidman Physiology Lab Anti-Tumorigenic Role of Brain Angiogenesis Inhibitor University of Alabama at Birmingham" About Virginea de Araujo Farias "Brain Angiogenesis Inhibitor (BAI
- Regulator of G protein signaling protein 6 alleviates acute lung injury by inhibiting inflammation and promoting cell self-renewal in mice
Oncology and Immunology Regulator of G protein signaling protein 6 alleviates acute lung injury by inhibiting
- Natural carboxyterminal truncation of human CXCL10 attenuates glycosaminoglycan binding, CXCR3A signaling and lymphocyte chemotaxis, while retaining angiostatic activity
In contrast, loss of the four endmost C-terminal residues did not affect the inhibitory properties of
- Neuroimmune interplay during type 2 inflammation: symptoms, mechanisms and therapeutic targets in atopic diseases
, Interleukin-33 receptor , Interleukin-4 receptor alpha , Interleukin-5 receptor alpha , JAK , JAK inhibitors
- High Metabolite Concentrations in Portal Venous Blood as a Possible Mechanism for Microbiota Effects on the Immune System, and Western Diseases
through insufficient G-protein coupled receptor (GPCR) signalling, or lack of histone deacetylase (HDAC) inhibition
- GPR176 Promotes Cancer Progression by Interacting with G Protein GNAS to Restrain Cell Mitophagy in Colorectal Cancer
The GPR176/GNAS complex inhibits mitophagy via the cAMP/PKA/BNIP3L axis, thereby promoting the tumorigenesis
- Dynamic Phosphoproteomics of BRS3 Activation Reveals the Hippo Signaling Pathway for Cell Migration
Yes-associated protein (YAP), and its association with cell migration was further confirmed by kinase inhibition
- Session II | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
oncolytic adenoviruses and anti-angiogenic molecules and is currently developing novel small molecule inhibitors
- Leukotriene B4 receptor 2 governs macrophage migration during tissue inflammation
of tailfin injury, we demonstrated that antisense morpholino-mediated knockdown of blt2a or chemical inhibition
- Gi/o GPCRs drive the formation of actin-rich tunneling nanotubes in cancer cells via a Gβγ/PKCα/FARP1/Cdc42 axis
dependent on the transactivation of the epidermal growth factor receptor (EGFR) and impaired by PI3K inhibition
- GPR176 promotes fibroblast-to-myofibroblast transition in organ fibrosis progression
Consequently, Gpr176 acts in a profibrotic manner, and inhibiting its activity could potentially prevent
- Delivery of US28 by incoming HCMV particles rapidly attenuates Akt activity to suppress HCMV lytic replication in monocytes
Inhibiting the dual phosphorylation of Akt prevented the lytic replication of US28Δ, and ectopic expression
- Mechanistic exploration of bioactive constituents in Gnetum gnemon for GPCR-related cancer treatment through network pharmacology and molecular docking
demonstrated the strong binding affinity of gnetin A, gnetin C, (-)-viniferin, and resveratrol dimer, thus inhibiting
- Deciphering a GPCR-lncRNA-miRNA Nexus: Identification of an Aberrant Therapeutic Target in Ovarian Cancer
More significantly, intratumoral delivery of UCA1-specific siRNAs inhibits the growth of cisplatin-refractory
- Lactate receptor GPR81 drives breast cancer growth and invasiveness through regulation of ECM properties and Notch ligand DLL4
Delta-like-4 (DLL4), was strikingly downregulated upon GPR81 KD, and DLL4 KD elicited spheroid necrosis and inhibited